Drugs News and Research

RSS

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial report today in the journal Nature Medicine.

19 Oct 2023

Researchers profile new drug combinations to fight antibiotic-resistant bacteria

Antimicrobial resistance – occurring when pathogens can survive antibiotic treatment – is one of the most rapidly emerging global public health threats today.

19 Oct 2023

Virginia Tech researchers develop new drug design framework to fight COVID-19

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

19 Oct 2023

Feds try to head off growing problem of overdoses among expectant mothers

When Andria Peterson began working as a clinical pharmacist in the pediatric and neonatal intensive care units at St. Rose Dominican Hospital in Henderson, Nevada, in 2009, she witnessed the devastating effects the opioid crisis had on the hospital's youngest patients.

19 Oct 2023

Have weight loss practices changed over time based on obesity status or sex?

The changing trends in weight loss practices over the years.

19 Oct 2023

Deep learning algorithm identifies antimalarial drug as promising treatment for osteoporosis

Artificial intelligence has exploded in popularity and is being harnessed by some scientists to predict which molecules could treat illnesses, or to quickly screen existing medicines for new applications.

18 Oct 2023

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of which is guided by biomarker testing.

18 Oct 2023

Research suggests a potential new approach for halting the spread of pancreatic cancer

A new study carried out in mice, led by Queen Mary University of London, has identified cells that drive the spread of pancreatic cancer and discovered a weakness in these cells that could be targeted using existing drugs.

18 Oct 2023

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Research published in the Journal of Internal Medicine indicates that SARS-CoV-2 infection may worsen lower urinary tract symptoms (LUTS) in men.

18 Oct 2023

Pregnant and addicted: Homeless women see hope in street medicine

Five days after giving birth, Melissa Crespo was already back on the streets, recovering in a damp, litter-strewn water tunnel, when she got the call from the hospital.

18 Oct 2023

Lung chip model offers new insights into how radiation damages the lungs

The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of many cell types in the lung, causing acute and sustained inflammation, and in the longer term, the thickening and scarring of lung tissue known as fibrosis.

17 Oct 2023

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

17 Oct 2023

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress 2023 in Madrid, Spain.

17 Oct 2023

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

The study reveals a significant increase in the usage of GLP-1 receptor agonists, particularly Ozempic and Trulicity, for weight management and Type 2 diabetes in the U.S. from 2014 to 2022. Amidst rapid growth and shortages, the paper calls for evidence-based decision-making to ensure stable medication supply and effective treatment.

17 Oct 2023

Researchers receive NCI grant for the development of new pancreatic cancer therapies

Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.

17 Oct 2023

Strengthening the immune system to fight cytomegalovirus on its own

Some viruses can be dormant throughout a person's life and cause no harm but become dangerous when the immune system is weakened.

17 Oct 2023

Mitochondrial protein CHCHD2 plays important role in glioblastoma progression

Glioblastoma is the most common type of brain tumor that affects adults and, unfortunately, still remains incurable. In a new study, researchers have demonstrated that a specific mitochondrial protein plays an important role in glioblastoma, and can therefore be used as a potential target to reduce tumors.

17 Oct 2023

Drugs News and Research

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

Researchers profile new drug combinations to fight antibiotic-resistant bacteria

Virginia Tech researchers develop new drug design framework to fight COVID-19

Feds try to head off growing problem of overdoses among expectant mothers

Have weight loss practices changed over time based on obesity status or sex?

Deep learning algorithm identifies antimalarial drug as promising treatment for osteoporosis

Precision oncology therapies account for nearly half of new cancer drug approvals since 1998

Research suggests a potential new approach for halting the spread of pancreatic cancer

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Pregnant and addicted: Homeless women see hope in street medicine

Lung chip model offers new insights into how radiation damages the lungs

New treatment options offer hope for patients with non-small cell lung cancer

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

Researchers receive NCI grant for the development of new pancreatic cancer therapies

Strengthening the immune system to fight cytomegalovirus on its own

Mitochondrial protein CHCHD2 plays important role in glioblastoma progression

Texas A&M researchers win NIH grant to study metabolism in people with Down syndrome

“Goblet cells” play an important role in the development of allergic conjunctivitis

For people with sickle cell disease, ERs can mean life-threatening waits

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News